CEL-SCI Corp (CVM)
0.5987
-0.01
(-0.96%)
USD |
NYAM |
Nov 22, 14:25
CEL-SCI Total Liabilities (Quarterly): 15.60M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 15.60M |
| March 31, 2024 | 15.74M |
| December 31, 2023 | 16.06M |
| September 30, 2023 | 17.31M |
| June 30, 2023 | 17.53M |
| March 31, 2023 | 18.05M |
| December 31, 2022 | 17.97M |
| September 30, 2022 | 18.36M |
| June 30, 2022 | 18.16M |
| March 31, 2022 | 19.03M |
| December 31, 2021 | 18.32M |
| September 30, 2021 | 19.34M |
| June 30, 2021 | 19.85M |
| March 31, 2021 | 19.03M |
| December 31, 2020 | 20.78M |
| September 30, 2020 | 20.81M |
| June 30, 2020 | 23.02M |
| March 31, 2020 | 22.51M |
| December 31, 2019 | 22.54M |
| September 30, 2019 | 22.49M |
| June 30, 2019 | 27.34M |
| March 31, 2019 | 23.80M |
| December 31, 2018 | 23.23M |
| September 30, 2018 | 29.59M |
| June 30, 2018 | 22.95M |
| Date | Value |
|---|---|
| March 31, 2018 | 26.15M |
| December 31, 2017 | 27.01M |
| September 30, 2017 | 26.26M |
| June 30, 2017 | 13.75M |
| March 31, 2017 | 11.80M |
| December 31, 2016 | 5.495M |
| September 30, 2016 | 25.57M |
| June 30, 2016 | 18.25M |
| March 31, 2016 | 18.46M |
| December 31, 2015 | 16.45M |
| September 30, 2015 | 33.32M |
| June 30, 2015 | 17.57M |
| March 31, 2015 | 12.38M |
| December 31, 2014 | 7.714M |
| September 30, 2014 | 8.787M |
| June 30, 2014 | 10.12M |
| March 31, 2014 | 14.46M |
| December 31, 2013 | 9.685M |
| September 30, 2013 | 4.138M |
| June 30, 2013 | 6.951M |
| March 31, 2013 | 6.945M |
| December 31, 2012 | 10.39M |
| September 30, 2012 | 9.04M |
| June 30, 2012 | 10.91M |
| March 31, 2012 | 12.14M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.60M
Minimum
Jun 2024
23.02M
Maximum
Jun 2020
18.95M
Average
18.36M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Protalix BioTherapeutics Inc | 29.13M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.07M |
| Shareholders Equity (Quarterly) | 8.473M |